Skip to main content
. 2022 May 27;12:814895. doi: 10.3389/fonc.2022.814895

Table 1.

Patient characteristics.

Clinical variables Number (n = 354) Percentage (%)
Gender (Male/female) 302/52 85/15
Age (years, median) 54 (20–77)
Site
Oropharynx 181 51.1
Hypopharynx 75 21.2
Larynx 98 27.7
T stage
T1, T2 89 25.1
T3, T4 265 74.9
Clinical node(cN)
cN+ 264 74.6
cN− 90 25.4
Radiological positive node(rN)
rN+ 244 69
rN− 110 31
Radiological extranodal extension(rENE)
rENE+ 140/244 57.4
rENE− 104/244 42.6
Response
CR 204 57.6
PD 24 6.8
IR (SD + PR) 126 35.6
Status
Alive 208 58.8
Deaths 146 41.2
Deaths
Death due to disease 117/146 80.1
Death due to other cause (drug toxicity, second primary, tuberculosis, and unknown) 29/146 19.9
Histopathological differentiation
WDSCC 2 0.6
MDSCC 65 18.3
PDSCC 107 30.2
SCC not specified 180 50.9
Recurrence
Present 158 44.7
Absent 196 55.3
Recurrence site
Local 58 36.7
Nodal 35 22.2
Distant 33 20.9
Combination 32 20.3

CR, complete response; PR, partial response; PD, progression of disease; SD, stable disease; IR, incomplete response; WDSCC, well-differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma; SCC, squamous cell carcinoma.